Cargando…
Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase‐induced cardiomyopathy: involvement of mitofusin‐2
BACKGROUND AND PURPOSE: The anthracycline doxorubicin (DOX), although successful as a first‐line cancer treatment, induces cardiotoxicity linked with increased production of myocardial ROS, with Nox2 NADPH oxidase‐derived superoxide reported to play a key role. The aim of this study was to identify...
Autores principales: | McLaughlin, Declan, Zhao, Youyou, O'Neill, Karla M, Edgar, Kevin S, Dunne, Philip D, Kearney, Anna M, Grieve, David J, McDermott, Barbara J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647180/ https://www.ncbi.nlm.nih.gov/pubmed/28261787 http://dx.doi.org/10.1111/bph.13773 |
Ejemplares similares
-
Downregulation of PPARα during Experimental Left Ventricular Hypertrophy is Critically Dependent on Nox2 NADPH Oxidase Signalling
por: Harvey, Adam P., et al.
Publicado: (2020) -
The Role of the NADPH Oxidase NOX2 in Prion Pathogenesis
por: Sorce, Silvia, et al.
Publicado: (2014) -
Structure of the core human NADPH oxidase NOX2
por: Noreng, Sigrid, et al.
Publicado: (2022) -
The NADPH Oxidase Nox4 and Aging in the Heart
por: Ago, Tetsuro, et al.
Publicado: (2010) -
NOX, NOX Who is There? The Contribution of NADPH Oxidase One to Beta Cell Dysfunction
por: Taylor-Fishwick, David A.
Publicado: (2013)